IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION - EVIDENCE THAT NITRIC-OXIDE ABNORMALITY IS NOT LOCALIZED TO A SINGLE SIGNAL-TRANSDUCTION PATHWAY

Citation
Ja. Panza et al., IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION - EVIDENCE THAT NITRIC-OXIDE ABNORMALITY IS NOT LOCALIZED TO A SINGLE SIGNAL-TRANSDUCTION PATHWAY, Circulation, 91(6), 1995, pp. 1732-1738
Citations number
58
Categorie Soggetti
Cardiac & Cardiovascular System",Hematology
Journal title
ISSN journal
00097322
Volume
91
Issue
6
Year of publication
1995
Pages
1732 - 1738
Database
ISI
SICI code
0009-7322(1995)91:6<1732:IEVIPW>2.0.ZU;2-2
Abstract
Background Patients with essential hypertension have abnormal endothel ium-dependent vascular relaxation, largely related to reduced bioactiv ity of nitric oxide (NO). The purpose of the present investigation was to determine whether this defect is due to a deficit at the specific intracellular signal-transduction pathway level or is a consequence of a more generalized endothelial abnormality. Methods and Results The r esponses of the forearm vasculature to acetylcholine and bradykinin (e ndothelium-dependent agents that act through different signal transduc tion pathways) and to sodium nitroprusside (a direct dilator of vascul ar smooth muscle) were studied in 10 hypertensive patients (5 men, 5 w omen; aged 48+/-9 years old [mean+/-SD]) and 12 control subjects (6 me n, 6 women; aged 48+/-7 years old). To determine the contribution of N O to bradykinin-induced vasodilation, the vascular responses to bradyk inin were also measured after administration of N-G-monomethyl-L-argin ine, an arginine analogue that inhibits the synthesis of NO. Drugs wer e infused into the brachial artery, and forearm blood flow was measure d by strain-gauge plethysmography. The response to acetylcholine was s ignificantly blunted in hypertensive patients (maximal blood flow, 7.5 +/-2 versus 16.6+/-8 mL . min(-1). 100 mL(-1) in control subjects [mea n+/-SD]; P<.005). Similarly, the vasodilator effect of bradykinin was significantly reduced in hypertensive patients compared with control s ubjects (maximal blood flow, 8.7+/-2 versus 15.8+/-6 mL . min(-1). 100 mL(-1) in control subjects; P<.005). A significant correlation was fo und between the maximal blood flow with acetylcholine and that with br adykinin (r=.89). No significant differences were found between the tw o groups for vascular response to sodium nitroprusside. N-G-monomethyl -L-arginine significantly blunted the response to bradykinin in contro l subjects (maximal blood flow decreased from 15.8+/-6 to 10.1+/-2 mL . min(-1). 100 mL(-1), P<.003). In contrast, inhibition of NO synthesi s did not modify the response to bradykinin in hypertensive patients ( maximal blood flow, 8.7+/-2 and 8.5+/-3 before and during infusion of N-G-monomethyl-L-arginine, respectively; P=NS). As a consequence, the response to bradykinin after inhibition of NO synthesis was not signif icantly different between the two groups. Conclusions Patients with es sential hypertension have impaired endothelium-dependent vasodilator r esponses to both acetylcholine and bradykinin. These findings indicate that the endothelial dysfunction in this condition is not related to a specific defect of a single intracellular signal-transduction pathwa y and suggest a more generalized abnormality of endothelial vasodilato r function.